These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 6173895
1. Cerebrospinal fluid amine metabolites in delirium tremens. Banki CM, Molnar G. Psychiatr Clin (Basel); 1981; 14(3):167-77. PubMed ID: 6173895 [Abstract] [Full Text] [Related]
2. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S. Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099 [Abstract] [Full Text] [Related]
3. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women. Banki CM, Molnar G. Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376 [Abstract] [Full Text] [Related]
4. 5-Hydroxyindolacetic acid and homovanillic acid are not involved in the cerebrospinal fluid after a seizure in patients with Delirium Tremens. Couvreur G, Demougeot C, Maugras C, Marie C, Beley P, Giroud M. Neurol Res; 2002 Sep; 24(6):599-600. PubMed ID: 12238628 [Abstract] [Full Text] [Related]
5. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT. Abrams R, Essman WB, Taylor MA, Fink M. Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078 [Abstract] [Full Text] [Related]
6. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms. Banki CM, Molnar G, Vojnik M. J Affect Disord; 1981 Jun; 3(2):91-9. PubMed ID: 6166645 [Abstract] [Full Text] [Related]
7. Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression. Banki CM, Molnar G, Fekete I. Arch Psychiatr Nervenkr (1970); 1981 Jun; 229(4):345-53. PubMed ID: 6164353 [Abstract] [Full Text] [Related]
8. Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. Banki CM. J Neural Transm; 1981 Jun; 50(2-4):89-101. PubMed ID: 6165805 [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 1. Background variables. Banki CM, Vojnik M, Molnar G. J Affect Disord; 1981 Jun; 3(2):81-9. PubMed ID: 6166644 [Abstract] [Full Text] [Related]
14. Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history. Lindström LH. Psychiatry Res; 1985 Apr; 14(4):265-73. PubMed ID: 2410940 [Abstract] [Full Text] [Related]
19. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard. Javors MA, Bowden CL, Maas JW. J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084 [Abstract] [Full Text] [Related]
20. Neurophysiological measures related to levels of 5-hydroxyindoleacetic acid, homovanillic acid and tryptophan in cerebrospinal fluid of psychiatric patients. Gottfries CG, von Knorring L, Perris C. Neuropsychobiology; 1976 Dec 12; 2(1):1-8. PubMed ID: 1004696 [Abstract] [Full Text] [Related] Page: [Next] [New Search]